首页> 外文期刊>European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) >Electroporation adopting trains of biphasic pulses enhances in vitro and in vivo the cytotoxic effect of doxorubicin on multidrug resistant colon adenocarcinoma cells (LoVo)
【24h】

Electroporation adopting trains of biphasic pulses enhances in vitro and in vivo the cytotoxic effect of doxorubicin on multidrug resistant colon adenocarcinoma cells (LoVo)

机译:采用双相脉冲序列的电穿孔增强了阿霉素对多药耐药结肠腺癌细胞(LoVo)的细胞毒性作用

获取原文
获取原文并翻译 | 示例
           

摘要

Few articles in the literature have focused on electroporation as a strategy to reverse multidrug resistance (MDR) of tumour cells and they are mostly limited to the improved efficacy of bleomycin. We tested the application of trains of biphasic pulses to cell suspensions and to murine xenografts as a strategy to increase the uptake of doxorubicin (DOX) and to enhance its cytotoxicity against chemoresistant cells. The human colon adenocarcinoma cell line LoVo DX, expressing MDR phenotype with high levels of P-glycoprotein (P-gp), has been used. The in vitro and in vivo studies gave the following results: (i) the application of the electric pulses to the cell suspension, immediately before DOX administration, induced a significant increase of drug retention; (ii) confocal microscopy observations showed a remarkable increase of intranuclear accumulation of DOX induced by electroporation; (iii) cell survival assay revealed a decrease of cell viability in the cultures treated with the combination of electroporation and doxorubicin; (iv) scanning electron microscopy observations revealed consistent morphological changes after the combined exposure to electroporation and doxorubicin; (v) in implanted mice the combined treatment induced an evident slowdown on the tumour growth when compared to treatment with DOX alone; (vi) histopathological analysis evidenced tumour destruction and its replacement by scar tissue in the tumours treated with the combination of doxorubicin and electroporation.
机译:文献中很少有文章将电穿孔作为逆转肿瘤细胞多药耐药性(MDR)的策略,并且它们大多局限于博来霉素的改良功效。我们测试了双相脉冲序列在细胞悬浮液和鼠类异种移植物中的应用,以此作为增加对阿霉素(DOX)摄取并增强其对化学耐药细胞的细胞毒性的策略。已使用表达具有高水平P-糖蛋白(P-gp)的MDR表型的人结肠腺癌细胞LoVo DX。体外和体内研究得出以下结果:(i)在DOX给药之前,立即将电脉冲施加到细胞悬液上导致药物滞留量显着增加; (ii)共聚焦显微镜观察显示,电穿孔诱导的DOX的核内积累显着增加; (iii)细胞存活试验表明,在用电穿孔和阿霉素的组合处理的培养物中,细胞活力降低了; (iv)扫描电子显微镜观察显示,在电穿孔和阿霉素的联合暴露后,形态学变化一致; (v)与仅用DOX治疗相比,组合治疗在小鼠体内引起明显的肿瘤生长减慢; (vi)组织病理学分析证明在用阿霉素和电穿孔联合治疗的肿瘤中,肿瘤被破坏并被瘢痕组织替代。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号